The global aquaculture therapeutics market is on a robust growth trajectory, projected to expand from USD 1.74 billion in 2023 to USD 3.98 billion by 2033, registering a compound annual growth rate (CAGR) of 8.6% over the forecast period. This growth is driven by the increasing demand for sustainable aquaculture practices and the rising prevalence of aquatic diseases impacting fish farming and seafood production.
Aquaculture therapeutics, which include vaccines, antibiotics, and probiotics, are crucial in ensuring the health and productivity of aquatic species. With the global surge in seafood consumption and the need to meet dietary protein demands, the aquaculture sector is turning to advanced therapeutics for disease management and improved yield.
Furthermore, regulatory support for sustainable aquaculture practices and technological advancements in aquaculture healthcare solutions are expected to propel market expansion. However, challenges such as the overuse of antibiotics and stringent regulatory approvals for new products may impact market dynamics.
A Full Report Overview – https://www.futuremarketinsights.com/reports/aquaculture-therapeutics-market
Key Takeaways:
- The aquaculture therapeutics market is set to grow at an 8.6% CAGR, reaching $3.98 billion by 2033.
- Rising seafood consumption and the need for sustainable aquaculture practices are driving demand.
- Innovations in vaccines and probiotics are enhancing disease management in aquatic farming.
- Regulatory challenges and concerns over antibiotic overuse could pose hurdles for market growth.
Competitive Analysis
Some key growth tactics companies employ in aquaculture therapeutics to augment profitability and enhance their market share include acquisition, merger, partnership & agreement, and geographical expansion.
Recent Developments:
- ViAqua Therapeutics, a well-known micro-encapsulation company, has developed an RNAi particle encapsulated in feed for effective oral administration and delivery of viral disease treatment.
- BioKind, a United Kingdom, manufactures aquaculture feed. The company uses natural fermentation on agricultural waste to produce traceable and sustainable proteins. BioKind’s technology reduces overfishing and excessive land use associated with the current animal food sector.
Key Players
- TunaTech GmbH
- ViAqua Therapeutics Ltd
- Alpharma, Inc.
Key Segments Covered
By Product Type:
- Chorionic Gonadotropin
- Formalin Solution
- Florfenicol
- Oxytetracycline
- Tricaine Methane Sulfonate
- Hydrogen Peroxide
- Sulfadimethoxine/Ormetoprim Combination
By End User:
- Veterinary Pharmacies
- E-commerce
- Veterinary Clinics
- Veterinary Hospitals
Key Regions Covered:
- North America
- United States
- Canada
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Europe
- Germany
- United Kingdom
- France
- Spain
- Russia
- Rest of Europe
- Japan
- Asia Pacific Excluding Japan
- China
- India
- Malaysia
- Singapore
- Australia
- Rest of Asia Pacific Excluding Japan (APEJ)
- The Middle East and Africa
- GCC Countries
- Israel
- South Africa
- Middle East and Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
